The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Codiak BioSciences, Inc. quarterly Current Ratio history and growth rate from Q2 2021 to Q3 2022.
Codiak BioSciences, Inc. Current Ratio for the quarter ending September 30, 2022 was 426 %, a 27.3% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period
Value
YoY Chg
Change %
Date
Q3 2022
426
-159
-27.3%
Sep 30, 2022
Q2 2022
433
-18.6
-4.11%
Jun 30, 2022
Q1 2022
463
Mar 31, 2022
Q4 2021
517
Dec 31, 2021
Q3 2021
585
Sep 30, 2021
Q2 2021
452
Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.